Loading clinical trials...
Loading clinical trials...
A Phase 1 Study of Evaluating Preliminary Safety and Efficacy of CT101a in the Treatment of Relapsed or Refractory (r/r) AML Patients
Conditions
Interventions
CT101a
Locations
1
China
The First Affiliated Hospital，College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Start Date
December 28, 2021
Primary Completion Date
August 28, 2022
Completion Date
April 3, 2023
Last Updated
May 16, 2023
NCT06859424
NCT06994676
NCT07450872
NCT06158828
NCT03050268
NCT07148180
Lead Sponsor
Zhejiang University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions